Calendrier des promotions Coral Laboratories Limited
Calendrier avancé
Graphique simple
À propos de l'entreprise Coral Laboratories Limited
Coral Laboratories Limited manufactures and sells pharmaceutical formulations in India, Ethopia, and internationally. The company offers antibiotics/antibacterial products, including antifungal, antiemetic, analgesics/antipyretic/antiinflammatory, antispasmodic, anticold, antiallergic, antiasthmatic, antidiabetic, antiemetics, anthelmentic, thyroid, and antiprotozoal/antiamebic products; antimalarial drugs, antipsychotic drugs, gastro-intestinal drugs, kits, muscle relaxants, cough suppressant/expectorant products, cardiovascular medicines, oral antiseptic preparations, mouthwashes, calcium preparations, and appetizers; and nutritional, protein, and iron supplements, as well as other products. It also provides cephalosporin, beta lactam, and lyophilized injectable products; eye/ear/nose drops; nasal sprays and metered dose inhales; and large volume parenteral products. In addition, the company offers various nutraceutical products, such as dietary supplements, herbal/phytochemicals, multivitamins, and nutrients, as well as OTC products. It provides its products in various dosage forms, including tablets, capsules, low RH facilities, liquid orals, liquids and powders, dry syrups, drops, ointment and creams, gels and lotions, granules powders, injectables, nasal sprays, and suppositories. Coral Laboratories Limited was incorporated in 1994 and is headquartered in Mumbai, India.Paramètres de base
Industry
Pharmaceuticals
Sector
Health Care
Валюта
inr
Валюта отчета
inr
Див.доход ао
0.23
Дивиденд ао
2
Сайт
Grade
Sous-estimation
Nom | Signification | Grade |
P/S | 1.72 | 8 |
P/BV | 0.7979 | 9 |
P/E | 8.97 | 9 |
Efficacité
Nom | Signification | Grade |
ROA | 8.31 | 3 |
ROE | 9.5 | 3 |
ROIC | 0 | 0 |
Dividendes
Nom | Signification | Grade |
Rendement en dividendes | 0.23 | 0.58 |
DSI | 0.9286 | 9.29 |
Croissance moyenne du dividende | 0.2778 | 0.46 |
Devoir
Nom | Signification | Grade |
Debt/EBITDA | 0 | 10 |
Debt/Ratio | 0 | 10 |
Debt/Equity | 0.1588 | 10 |
Impulsion de croissance
Nom | Signification | Grade |
Rentabilité Revenue, % | 16.32 | 3 |
Rentabilité Ebitda, % | 0 | 5 |
Rentabilité EPS, % | 121.44 | 10 |
paper.price.prices
Prix | Common.min. | Common.max. | Changement | paper.changes_in_industry | paper.changes_in_index | |
common.calendar.number_days.1 | 609.75 ₹ | 0 ₹ | 0 ₹ | +11.55 % | 0 % | 0 % |
common.calendar.number_days.7d | 595.65 ₹ | 0 ₹ | 0 ₹ | +14.19 % | 0 % | 0 % |
common.calendar.number_days.30d | 769.05 ₹ | 0 ₹ | 0 ₹ | -11.55 % | 0 % | 0 % |
common.calendar.number_days.90d | 630.2 ₹ | 589.5 ₹ | 777.2 ₹ | +7.93 % | 0 % | 0 % |
common.calendar.number_days.180d | 780 ₹ | 589.5 ₹ | 808.65 ₹ | -12.79 % | 0 % | 0 % |
common.calendar.number_days.1y | 924 ₹ | 589.5 ₹ | 993.45 ₹ | -26.39 % | 0 % | 0 % |
common.calendar.number_days.3y | 241.5 ₹ | 220 ₹ | 993.45 ₹ | +181.66 % | 0 % | 0 % |
common.calendar.number_days.5y | 190.2 ₹ | 206.3 ₹ | 993.45 ₹ | +257.62 % | 0 % | 0 % |
common.calendar.number_days.10y | 92.45 ₹ | 92.45 ₹ | 1 134.2 ₹ | +649.11 % | 0 % | 0 % |
common.calendar.number_days.ytd | 754.8 ₹ | 589.5 ₹ | 813.85 ₹ | -9.88 % | 0 % | 0 % |
Gestion d'entreprise
Superviseur | Titre d'emploi | Paiement | Année de naissance |
Mr. Girish Madanlal Dhameja | Whole-Time Director | 1981 (44 année) | |
Ms. Sushma Shashi Kadkade | CFO & Non-Exec. Director | 1976 (49 années) | |
Ms. Ruchi Anjaria | Company Sec. & Compliance Officer | ||
Mr. Kapil K. Shah | Exec. Officer |
Informations sur l'entreprise
Adresse: India, Mumbai, #3B Patanwala Industrial Estate - Ouvrir dans google maps, Ouvrir les cartes yandex
Site web: http://corallab.com
Site web: http://corallab.com